Healthcare Industry Insights: January 2020

Thursday 30 January 2020

Orthopedic Implants Market Outlook, 2024

The global Orthopedic Implants Market is expected to reach USD 6.2 billion by 2024, according to a new report by Grand View Research, Inc. Major drivers, such as the surging geriatric population count and the increasing number of sports injuries are fueling the demand for the orthopedic prostheses globally.

The soaring number of road accidents and sports injuries is continually engendering the multitude of worldwide trauma cases. In addition, people above the age of 65 years are highly prone to orthopedic diseases and fractures since bone density progressively reduces with increasing age. Thus, the growth in the number of trauma cases and the escalating elderly population is further driving the target patient base for prosthetic implants.

On the other hand, the cost prohibitive nature of these implants coupled with the inadequate reimbursement coverage is the prime factor restraining the growth of the global market. In addition, the existent stringent regulatory framework and the frequent product recalls are some of the other factors further challenging the growth.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/orthopedic-implants-market

Further key findings from the study suggest:

The knee replacement segment captured the largest share of the global market in 2015, which is attributable mainly tothe high prevalence of osteoporosis and arthritis.
The orthopedic implants for long bones are anticipated to show the fastest growth rate owing to the constantly rising sports injuries and accident trauma cases.
North America captured the largest market share of 53.4% in 2015 and is expected to maintain its dominance throughout the forecast period. The presence of a well-defined regulatory framework, recommendations of government and healthcare agencies, and the current high adoption rate of minimally invasive procedures are the major factors supporting the growth of the market in North America.
Asia Pacific is anticipated to exhibit fast paced growth during the forecast period due mainly to therising disposable income, growing awareness with regard to improved and advanced orthopedic prostheses, progressively improving healthcare infrastructure, and the flourishing medical tourism industry are some of the factors rendering the Asia Pacific region attractive to the international players.
The global orthopedic implants market is fragmented with the presence of many local players. Thus, market players are adopting strategies including mergers and acquisitions and distribution partnerships to expand their overall market share and sustain themselves in the competition.
Some key players operating in this market include Zimmer Biomet Holdings, Inc., Stryker Corporation, DepuySynthes, Smith & Nephew plc, Wright Medical Group N.V, and Medtronic Plc.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Non-Invasive Brain Trauma Monitoring Devices Market by Product and End Use

The global Non-Invasive Brain Trauma Monitoring Devices Market is expected to reach USD 15.12 billion by 2024, according to a new report by Grand View Research, Inc. The rising burden of Traumatic Brain Injuries (TBI) is a leading cause of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. As a result, there are numerous initiatives taken at the regional and global levels to create awareness, which facilitated a heavy diagnosis rate, thus governing the growth of non-invasive brain trauma monitoring devices.

Technological advancements in this field are connected with accuracy, portability, and affordability, which are supporting the industry growth. For instance, recently available non-invasive intracranial pressure monitors, such as Transcranial Doppler (TCD), are accurate in positioning and creating a better pressure gradient and also bringing in more accuracy in the treatment.

The Minimally Invasive Surgeries (MIS) are less traumatic to patients and facilitate faster recovery with minimum complications. In minimally invasive neurological surgeries, non-invasive brain trauma monitoring devices play a critical role. Thus, the increasing volume of MIS is driving the industry’s growth.

The key target population in this industry includes people above 60 years. This section of the population is at a greater risk for TBIs and their co-morbidities. The global geriatric population is on arise and is a vital driver for this industry.

Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/non-invasive-brain-trauma-monitoring-devices-market

Further key findings from the study suggest:

Monitoring devices that include intracranial pressure monitors, MRI scanners, CT scanners, PET scanners, EEG, and MEG held a substantial share of around 60.0% in 2015. The high costs associated with this equipment and the increasing usage of these devices governed the growth of this segment.
The consumables sub-segment in the product segment is anticipated to witness lucrative growth over the forecast period. The repeat purchase of consumables and regular maintenance activities are expected to spur the demand for these products.

The market on the basis of end-use is segmented into hospitals, neurological centers, and other settings. The hospital segment dominated the end-use segment with over 75.0% of the revenue. The greater volume of surgeries performed in hospitals contributed to its growth.

On the contrary, neurological centers are expected to grow at a sturdy rate over the forecast period. The availability of specialized staff and advanced methodologies are likely to boost the demand for this segment.

North America dominated the non-invasive brain trauma monitoring devices market in 2015. The advanced healthcare system, high awareness level, and well-planned reimbursement policies helped this market to grow in this region. However, Asia Pacific is anticipated to witness significant growth over the forecast period.

Some key players operating in this industry include Natus Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, GE Healthcare, Advanced Brain Monitoring, CAS Medical Systems, Inc., Siemens, Compumedics Ltd., Medtronic Plc., and Integra LifeSciences. New product launches, co-developments, and acquisitions are the key initiatives in this industry.

For instance, in January 2013, Natus Medical acquired Astro-Med’s products included in monitoring and neurodiagnostic products. This acquisition helped the company to widen the portfolio of EEG systems.

About Grand View Research

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Molecular Cytogenetics Market Trends, Growth Opportunities and Overview Report

The global Molecular Cytogenetics Market size is expected to reach USD 3. 8 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 10.4% CAGR during the forecast period. Mapping of human genome, coupled with continuous technological advancements in cytogenetic techniques, has enabled researchers to gain insight into the disease-causing mechanism at a genomic as well as cellular level. Development in molecular technologies has helped in bridging the gap between molecular biology and cytogenetics, which was not possible using conventional cytogenetic techniques.

There is a continuous growth in awareness, and consequent adoption, of genetic tests for disease prognosis. These tests also help in designing further treatment regimes for widespread chromosomal abnormalities. This is sure to boost market growth.

Incorporation of high throughput sequencers in cytogenetic analysis is expected to significantly enhance market growth in the coming years. A number of researchers and scientists have begun converging cytogenetics laboratories with NGS as they complement each other. Hence, with exponential decline in sequencing price, this market is expected to grow at a lucrative pace.

However, ambiguous regulatory and reimbursement scenario in certain regions pertaining to implementation of genetic tests is expected to hamper the adoption of molecular cytogenetic techniques to a certain extent.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/molecular-cytogenetics-market

Further key findings from the report suggest:

Oncology held the largest share in the market in 2016 owing to the ability of CGH technology to facilitate in-depth studies for cancer etiology
Use of molecular cytogenetics in personalized medicine development is expected to grow lucratively during the forecast period. This is majorly due to a continuous shift toward targeted therapies for effective disease management
Requirement of consumables in the entire cytogenetics process is attributive for the largest share of this product category
Ongoing research projects for developing treatment regimen of different genetic conditions have allowed clinical and research laboratories to gain a significant share in the market
Pharmaceutical and biotech companies are expected to be a key source of revenue in the coming years. This is mainly because a number of pharmaceutical companies have expanded their business in the field of personalized medicine
Illumina, Inc.; Agilent Technologies, Inc.; Abbott; Bio-Rad Laboratories, Inc.; and Oxford Gene Technology are some prominent companies in the market. They are involved in development and commercialization of cytogenetics techniques
Some major service providers are Weill Cornell Medicine; WiCell Research Institute, Inc.; ARUP Laboratories; and Integrated Systems Engineering S.r.l.

About Grand View Research

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Patient Engagement Solutions Market Trends, Growth Opportunities and Overview Report

The global Patient Engagement Solutions Market size is expected to reach USD 56.92 billion by 2026, according to a new report by Grand View Research Inc. It is anticipated to expand at a CAGR of 20.43% during the forecast period. The supportive government initiatives and rising usage and awareness regarding mobile healthcare services are expected to impel the growth.

Rising prevalence of chronic conditions is the preliminary factor expected to boost the growth of the patient engagement solutions management market. The mortality rate of diabetic patients was over 1.0 million in 2012, as stated by the World Health Organization (WHO). This spike in the death rate of diabetic patients reflects the lack of knowledge about the causes, symptoms, and preventive measures. The present patient engagement systems aid the patients with educative information; thus, empowering them to make better healthcare decisions.

The patient engagement solutions assist hospitals in providing financial solutions for effective utilization of the allocated healthcare budget. The market players actively volunteer in obtaining patient feedback regarding the existent solutions to develop better patient engagement plat forms with enhanced quality. Such factors are projected to bode well for market expansion in the forthcoming years.

Moreover, favorable government initiatives and funding efforts undertaken to promote the incorporation of patient engagement solutions in the healthcare sector are anticipated to boost the market growth. For instance, in U.S., under the Health Information Technology for Economic and Clinical Health (HITECH) Act, the government spends around USD 20 billion annually on hospitals for the installation of Electronic Health Records (EHRs), which is expected to help improve the workflow and quality of treatment delivery.

Browse Details of Report@
https://www.grandviewresearch.com/industry-analysis/patient-engagement-solutions-market

Further key findings from the report suggest:

Web-based is expected to be the largest delivery mode segment, witnessing at a lucrative CAGR over the forecast period
North America is expected to lead over the forecast period with a revenue share of over 40.0% by 2026. Favorable government initiatives, such as the Affordable Care Act (ACA) initiated by President Obama and HITECH Act, are anticipated to drive the growth
Asia Pacific is anticipated to emerge as the fastest growing region with a CAGR of over 20.0% over the forecast period. Increasing healthcare investments, awareness regarding varying types of patient engagement portals, and geriatric population is estimated to catapult the demand
Some key players operating in the patient engagement solutions market include Allscripts Healthcare Solutions, Inc.; Cerner Corporation; Phytel, Inc.; Athenahealth, Inc.; McKesson Corporation; and MEDecision, Inc.
To curtail the competition, the key players actively engage in the development of new solutions that facilitate workflow of the existing platforms. For instance, Allscripts Healthcare Solutions, Inc. provides revenue cycle management solutions, which help maintain the financial health of the medical systems.

About Grand View Research

Wednesday 29 January 2020

Parenteral Nutrition Market Size, Share & Trends Analysis Report by B. Braun Melsungen AG; Baxter International, Inc.

The global Parenteral Nutrition Market size is expected to reach USD 8.26 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.8% during the forecast period. Increasing rate of natality and surging geriatric population is fueling the market growth.

As of 2014, the natality rate reported by the National Center for Health Statistics (NCHS) is 12.5 births per 1,000 populations in U.S. Furthermore, the percentage of lower weight infants was 8.0%, thereby boosting the demand for parenteral nutrition products in the country.

The realized natality is rising over the last decade and is anticipated to sustain growth over the forecast period. However, in 2011, a dip was witnessed in U.S. owing to alteration in fertility rate of the local female population. However, in the same year, hike in the number of births for foreign based immigrant citizens was also observed leading to an overall rise in birth rate.

Moreover, a large number of premature babies suffer from low weight as well as undeveloped immunity thus putting them at risk. Parenteral nutrition reduces the risk of infection and underdevelopment, thereby promoting its application.

As per the National Center for Healthcare Statistics, the premature birth rate of the U.S. is about 9.6% as of 2016, and the national authorities are working to reduce it to 8.1%.

In very low birth weight (VLBW) newborns, demand for parenteral nutrition is higher owing to low prospect of enteral nutrition. Hence, use of parenteral nutrition in premature infants results in improved intrauterine nutrient deposition, faster neurological development, and minimized risk of complications thus improving their chances for survival.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/parenteral-nutrition-market

Further key findings from the study suggest:

Single dose amino acid solution segment dominated the market in 2018 owing to increasing use of amino acid solutions that possess fewer side effects thus enhancing patient benefits
North America led the market in terms of revenue and accounted for 41.73% of the overall share in 2018. Presence of high research expenditure by private entities and government agencies in the healthcare sector and collaborations among medical device industry, regulatory authorities, and universities are responsible for the market growth
Some of the companies present in the parenteral nutrition market are B. Braun Melsungen AG; Baxter International, Inc.; Fresenius Kabi AG; Hospira, Inc.; Actavis, Inc.; Grifols International S.A.; Otsuka Pharmaceutical Factory, Inc.; and Sichuan Kelun Pharmaceutical Co. Ltd.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Diabetes Devices Market Trends and Analysis Report, 2024

The global Diabetes Devices Market size is expected to reach USD 35.5 billion by 2024, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 7.0% during the forecast period. Growing cases of diabetes, due to obesity, sedentary and unhealthy lifestyles, and several other factors, is expected to drive demand for diabetes devices over the next few years.

Obesity is believed to be one of the foremost factors leading to diabetes in individuals. According to WHO, in 2014, over 1.9 billion people were identified to be overweight, of which, around 600 million people were obese.

Some of the key companies in the global diabetes devices market are Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton, Dickinson and Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG, and Johnson & Johnson.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/diabetes-devices-market

Further key findings from the study suggest:

Constantly rising target population base is the primary factor driving market growth
Test strips capturedthe largest share in the monitoring and diagnostics device segment while insulin pens accounted for the largest revenue share among insulin delivery devices in 2016. This can be attributed to rapid adoption of these user-friendly, quick, and accurate devices for homecare use
North America is leading the regional market, followed by Europe. Advanced healthcare infrastructure and availability of technologically advanced products have driven the regional market
Key players in the market include Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton Dickinson and Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG and Johnson & Johnson.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Hemodynamic Monitoring Devices Market: Emerging Trends and Industry Outlook

The global Hemodynamic Monitoring Devices Market is expected to reach USD 1.4 billion by 2024, according to a new report by Grand View Research, Inc. The increasing demand for non-invasive monitoring techniques coupled with the rising prevalence of chronic illness is expected to drive the market over the forecast period.

The hemodynamic monitoring market is influenced by new technologies such as echocardiography, thoracic electrical bio-impedance and others that maybe used to non-invasively monitor parameters such as cardiac output, arterial pressure, blood oxygen level, and central venous pressure.

Furthermore, the rising population of critically ill patients coupled with defective healthcare facilities with drawbacks, such as understaffing, is propelling market players to develop minimal invasive hemodynamic monitoring devices that may be used in clinical and home care settings. Along with the new product development, the market is also anticipated to witness the development of technologies that help in the early diagnosis of shock and sepsis.

Furthermore, efforts by key industry players to understand critical illnesses at molecular levels leading to the development of efficient assessment products are expected to be witnessed over the forecast period. Hence, all these company strategies and the research conducted are eventually expected to promote market growth over the forecast period.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/hemodynamic-monitoring-devices-market

Further key findings from the study suggest:

The disposables segment is anticipated to be the largest segment by 2024. The rising sale of hemodynamic monitoring systems and increasing applications of these systems in home care settings, hospitals, and clinics are expected to boost the segment growth.
The non-invasive devices segment is expected to be the fastest growing hemodynamic monitoring market. Risks that include the development of arrhythmias due to the use of pulmonary artery catheter and the development of other methodologies that measure the cardiac output, such as echocardiographs, are the vital impact rendering drivers.
Asia Pacific is anticipated to be the fastest growing regions and is anticipated to contribute to about 20.0% of the global revenue by 2024. The strengthening of the distribution channels by companies and the registration of products in countries, such as China, India, Australia, and others, are expected to support the growth over the forecast period. For instance, LiDCO Group, in their 2016 prelim report emphasized on its strategy of appointing new distributors for the Australian and South East Asian region.
Major industry players are Edward Lifesciences, LiDCO Group Plc, Deltex Medical, Philips Medical, GE Healthcare, Noninvasive Medical Technologies, Inc., Tensys Medical, Inc., Cardio-Dynamics International, and Drager Medical, Inc. As mentioned above, the new product development is expected to drive the market over the forecast period.
For instance, in March 2016, the LiDCO Group received the U.S. FDA approval for the LiDCO unity and launched the product in the European region. Along the same time, LiDCO also succeeded in registering itself in China to explore untapped territories and increase their global presence.

About Us:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Tuesday 28 January 2020

Healthcare Analytics Market Size Worth $53.65 Billion By 2025

The global Healthcare/Medical Analytics Market is expected to reach USD 53.65 billion by 2025, according to a new report by Grand View Research, Inc. Increasing need to reduce healthcare expenditure among hospitals, and other healthcare providers is anticipated to boost growth in the market.

With the advent of data-enriched tools such as mHealth, eHealth, Electronic Health Records (EHR), and mobile applications, the communication gap between caregivers and patients has reduced. These tools generate tremendous data, which can be used for personalized treatments.

Generally, patients may hesitate to use these tools, which might affect the implementation of analytics. However, with the combination of artificial and human intelligence data analytics, which offer wide opportunities to further customize medical approaches, the demand for these tools is anticipated to increase over the forecast period.

Hospitals are now using healthcare analytics to manage the number of workers working in a particular shift, for instance, a hospital in Paris uses healthcare analytics to predict the number of patients that may be hospitalized. This data can be used to decide the number of staff members that will be needed for a particular shift, which helps in reducing labor cost in hospitals.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/healthcare-analytics-market

Further key findings from the report suggest:

Descriptive analytics held a significant share in 2015 owing to its applications in process optimization in organizations.
The services category dominated the component segment in 2015. Outsourcing of these big data services contributed towards their growth in leading to the high volume of services rendered.
The hardware systems category dominated the component segment, high-cost of the hardware contribute to its growth.
On-premise delivered analytic services dominated the delivery mode category with around 54.0% share in 2015.
Operational and administrative applications governed the applications segment and held a remunerative share in the year, 2015.
Payers held a significant market share in 2015 and the providers are anticipated to grow at a lucrative rate.
North America captured a significant share in the global market. Advanced healthcare infrastructure in this region and the growing per capita healthcare expenditure supported the greater consumption of these services.
The Asia Pacific region is expected to witness gainful growth attributable to the untapped opportunities in the countries including India and China.
Some key players operating in the healthcare analytics market include IBM Corporation, Oracle Corporation, SAS, Cerner Corporation, Allscripts Healthcare Solutions, Inc., Optum Health, Inc., and Verisk Analytics, Inc. The notable initiatives in the industry include new product launches, collaboration with government bodies, and investments directed towards R&D efforts.

About Grand View Research

Asthma Therapeutics Market Trends, Growth Opportunities and Overview Report

Global Asthma Therapeutics Market is expected to reach USD 25.6 billion by 2024, according to a new study by Grand View Research, Inc.

The increasing prevalence of asthma coupled with the adoption of biologics as a long-term treatment option to treat the severe form of asthma is expected to offer this market with lucrative growth opportunities. According to the statistics published by the World Allergy Journal, in May 2014, patients suffering from asthma registered around 300 million and the number is expected to soar due to a large number of individuals inclining towards unhealthy dietary habits and sedentary lifestyles.

In addition, patent expiration of branded drugs, such as Singulair, Advair and other major drugs during the forecast period has led to a stiff generic competition, which will negatively impact the asthma therapeutics market growth in the coming years. On the contrary, the introduction of biologics is accruing towards the increasing market share of the asthma therapeutics segment, and is anticipated to continue during the forecast period.

The enhanced demand for personalized medicine approach as opposed to the conventional medication prescription pattern for treatment of severe asthma is anticipated to aid the emergence of asthma therapeutics market in the future. In addition, development of technologically advanced products, such as pressurized metered dose inhalers and smart inhalers, equipped with sensor technology and inbuilt wireless communication system is further expected to propel the asthma therapeutics market growth in the next seven years.

Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/asthma-therapeutics-market

Further key findings from the study suggest:

The anti-inflammatory drug class is expected to exhibit rapid growth at a lucrative CAGR of 3.4% over the forecast period owing to the introduction of affordable and innovative biologics targeting the severe asthma condition. In addition, the awareness gained pertaining to the benefits rendered by the biologics and monoclonal antibodies is anticipated to exhibit an upward shift in the market expansion in the coming years.
The dry powder inhalers (DPIs) are expected to be the fastest growing segment due to the increasing adoption of these devices because of their high clinical efficiency than other inhalers. They are able to deliver both, small and large-sized drug components and dispense specialty engineered molecules. These related merits have spiked the adoption rates thereby contributing towards the risen market penetration.
Rising number of individuals opting for alternative treatment options, such as inhaled fixed-dose combination drugs for asthma medication is anticipated to serve this market with future growth opportunities. The inhalers market is expected to grow at a CAGR of above 2.0% over the forecast period.

Some of the key players operating in the asthma therapeutics market include AstraZeneca Plc, Philips Healthcare, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Roche Diagnostics, and Merck& Co., Inc.

Market leaders are focusing on the introduction of technologically advanced devices and novel, improved biologics to gain a competitive advantage. The asthma therapeutics segment has a very strong pipeline as there are almost 100 novel molecules that are in the development phase and manufacturers are focusing on the development of personalized medication. The aforementioned factors collectively strengthen the industry growth in the near future.

For instance, drug molecules, such as Cinquil by Teva Pharmaceutical Industries Ltd., Lebrikizumab by Roche (Phase III), Mastinib by AB Science (Phase II/III), and Bosatria by GlaxoSmithKline Plc (Phase III), are in the development stage undergoing clinical research trials. Their commercial availability during the forecast period is expected to provide a boost to this vertical.

About Grand View Research